Monica Araujo

Monica Araujo

Auto-generated profile, based on publicly available information

Monica Araujo

Division of Human Genetics, School of Pathology, Faculty of Health Sciences University of the Witwatersrand and the National Health Laboratory Services Johannesburg South Africa

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2024 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
NMNerina Chrisna Van Der Merwe
Nerina Chrisna Van Der Merwe
IBInes Buccimazza
Ines Buccimazza
BRBianca Rossouw
Bianca Rossouw
MAMonica Araujo
Monica Araujo
KNKholiwe S Ntaita
Kholiwe S Ntaita
JOJaco Oosthuizen
Jaco Oosthuizen
Purpose: Genetically predisposed breast cancer (BC) patients represent a minor but clinically meaningful subgroup of the disease, with 25% of all cases associated with actionable variants in BRCA1/2. Diagnostic implementation of next-generation sequencing (NGS) resulted in the rare identification of BC patients with double heterozygosity for deleterious variants in genes partaking in homologous recombination repair of DNA. As clinical heterogeneity poses challenges for genetic counseling, this study focused on the occurrence and clinical relevance of double heterozygous BC in South Africa. Methods: DNA samples were diagnostically screened using the NGS-based Oncomine™ BRCA Expanded Research Assay. Data was generated on the Ion GeneStudio S5 system and analyzed using the Torrent Suite™ and reporter software. The clinical significance of the variants detected was determined using international variant classification guidelines and treatment implications. Results: Six of 1600 BC patients (0.375%) tested were identified as being bi-allelic for two germline likely pathogenic or pathogenic variants. Most of the variants were present in BRCA1/2, including two founder-related small deletions in three cases, with family-specific variants detected in ATM, BARD1, FANCD2, NBN, and TP53. The scientific interpretation and clinical relevance were based on the clinical and tumor characteristics of each case. Conclusion: This study increased current knowledge of the risk implications associated with the co-occurrence of more than one pathogenic variant in the BC susceptibility genes, confirmed to be a rare condition in South Africa. Further molecular pathology-based studies are warranted to determine whether clinical decision-making is affected by the detection of a second pathogenic variant in BRCA1/2 and TP53 carriers.

15 August 2025 in Journal of Genetic Counseling
Verified
Journal Article
Open access
EGElzette Gilfillan
Elzette Gilfillan
MAMonica Araujo
Monica Araujo
JKJennifer Kromberg
Jennifer Kromberg
TWTina‐Marie Wessels
Tina‐Marie Wessels
KFKatryn Fourie
Katryn Fourie
Genetic counseling has evolved from focusing solely on congenital anomaly prevention to incorporating psychological counseling. Traditionally, its goal has been to enhance patient care by providing clinical information and facilitating psychological adjustment. However, with the rise of genomics and complex testing technologies, genetic counselors now engage in education, research, clinical practice, and laboratory roles. A previous study from 2013 described the role of genetic counselors in South Africa. This current study provides an updated perspective on these findings and how these roles have diversified. Registered independent genetic counselors were invited via email to complete an electronic survey adapted from the previous study conducted in 2013. The survey collected data on information pertaining to (1) demographics, (2) genetic counseling experience and employment, and (3) work/clinical practice. Data were analyzed using descriptive statistics. Of 44 contacted genetic counselors, 29 responded. Most were female (97%), under 40 years old (60%), and had practiced for less than 10 years (59%). Although many genetic counselors took on multiple responsibilitiessuch as clinical, administrative, research, and teaching—the proportion primarily working in clinical roles declined from 75% (12/16) in 2013 to 45% (10/22) in 2023. Notably, genetic counselors involved in teaching and training had significantly fewer years in practice (p = 0.0396; CI 95%), suggesting a loss of expertise in academic centers. A new trend observed since 2013 is laboratory‐based responsibilities, with 68% of participants reporting duties in this area. The role of genetic counselors in South Africa has expanded substantially over the past decade, with a shift away from predominantly clinical roles. These findings highlight the need for adaptation of training programs and strategic workforce planning to retain expertise in academic centers and ensure the continued growth of the profession.

31 January 2026 in Familial Cancer
Verified
Journal Article
Open access
PDF file
BRBianca Rossouw
Bianca Rossouw
MAMonica Araujo
Monica Araujo
AKAmanda Krause
Amanda Krause
FBFiona Baine-Savanhu
Fiona Baine-Savanhu
This scoping review explored genetic variants associated with hereditary ovarian cancer in women of African ancestry. Around 20% of ovarian cancers are hereditary, with BRCA1 and BRCA2 variants accounting for 20–55% of these cases, while other implicated genes include BRIP1, ATM, RAD51C, RAD51D , and the Lynch syndrome genes. The genetic basis of ovarian cancer in women of African ancestry, however, remains poorly understood. Accurate diagnosis of hereditary cancer syndromes is crucial given their personal and familial implications, informing patient management, surveillance, and cascade testing for at-risk relatives. Eligible studies included women of African ancestry with confirmed primary ovarian, peritoneal, or fallopian tube cancer who underwent germline genetic testing for hereditary cancer syndromes. Studies based solely on somatic testing or genome-wide association approaches were excluded. A comprehensive search of PubMed, Scopus, Web of Science, Google Scholar, and ProQuest Dissertations and Theses Global was conducted. Two reviewers independently screened citations and extracted data using a standardized form, and results were summarised narratively and in tables according to JBI scoping review guidelines. Thirty studies were included, primarily involving African American and North African participants. Only four focused specifically on hereditary ovarian cancer; the remainder primarily examined breast cancer cohorts with some ovarian cancer cases. Across these studies, 75 pathogenic variants were identified in 110 families, with 92% in BRCA1 or BRCA2 . Research on hereditary ovarian cancer in women with African ancestry remains extremely limited, highlighting the urgent need for broader next-generation sequencing studies to inform clinical care.

26 June 2026 in Journal of Genetic Counseling
Verified
Journal Article
Open access
SSSamantha Schnell
Samantha Schnell
ZGZandisiwe Goliath
Zandisiwe Goliath
BSBarry Shingwenyana
Barry Shingwenyana
ISIngrid Smit
Ingrid Smit
BRBianca Rossouw
Bianca Rossouw
ZLZané Lombard
Zané Lombard
Exome sequencing (ES) has become a valuable approach for diagnosing developmental disorders (DD), improving the diagnostic yield to up to 40%, and offering a potential end to the diagnostic odyssey experienced by many families. However, there remains a scarcity of studies assessing the lived experiences of parents and caregivers of individuals with DD, particularly within an African context. From the Deciphering Developmental Disorders in Africa (DDD‐Africa) study, 101 parents from 97 families who received ES results for their child with a previously undiagnosed DD participated in this sub‐study, which aimed to explore parents' expected utility of ES results and the psychological, social, and emotional impacts of receiving such results. Before result feedback consultations, researcher‐administered pre‐result feedback questionnaires were completed to determine parents' expectations of ES results and their motivations for seeking a confirmed diagnosis. Consultation summary notes were analyzed using a deductive, literature‐informed quantitative content analysis to identify psychological aspects that arose immediately after receiving results. The vast majority of parents, 98 of 101 (97.0%), expressed that they expected results to help them gain knowledge and understanding of their child's condition, and many ranked gaining a better understanding of their child's condition and potential future health problems as their primary motivator for seeking a confirmed diagnosis. Receiving a confirmed diagnosis was overwhelming and emotional for 39 of 97 (40.2%) families and elicited complex emotional responses. Results brought relief and/or a sense of resolution to 42 of 97 (43.3%) families, while 32 of 97 (34.5%) were accepting of their child's condition before receiving a result and 20 of 97 (20.6%) families experienced grief or a loss of hope. This study accentuates the importance of confirming a genetic diagnosis in individuals with DD, with parents expecting results to enhance their understanding of their child's condition, its cause, and any future health problems, illustrating the importance of genetic counseling in preparing and supporting families for ES result feedback.

30 September 2026 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SSSamantha Schnell
Samantha Schnell
KFKatryn Fourie
Katryn Fourie
EGElzette Gilfillan
Elzette Gilfillan
BRBianca Rossouw
Bianca Rossouw
BSBarry Shingwenyana
Barry Shingwenyana
MAMonica Araujo
Monica Araujo
This invited commentary explores the paradox of progress in genetic counselling in South Africa, where established training programmes and professional recognition have not yet translated into sustainable clinical genetic services. Drawing on workforce data and insights into training, employment and service delivery, the authors highlight how limited funded public‐sector posts, geographic concentration of services and loss of professionals from patient‐facing roles constrain equitable access to genetic counselling. The commentary aims to support coordinated workforce planning and investment to ensure that the expansion of genomic medicine is accompanied by accessible, sustainable and equitable genetic counselling services.

16 April 2026 in Journal of Genetic Counseling
Verified
Journal Article
Open access
RCReagan Chidrawi
Reagan Chidrawi
MAMonica Araujo
Monica Araujo
KFKatryn Fourie
Katryn Fourie
Having first emerged in the 1970s, genetic counseling is a relatively young profession in South Africa (SA). Historically, genetic counselors (GCs) in SA have been employed through academic and public health institutions, with only a few practicing in private healthcare. Recently there has been a noticeable shift in the employment trends of GCs worldwide and in SA, transitioning away from patient‐facing roles and gravitating toward practice in new or expanded roles. It is, therefore, becoming more common to find GCs employed in laboratory, research, and industry settings. These roles typically involve far less direct patient care, redefining the role of a GC. Although this trend has been researched elsewhere, mainly in the United States of America (USA) and Canada, it has yet to be explored locally. Therefore, this qualitative study aimed to explore the perspectives and experiences of GCs employed in non‐direct patient care (NDPC) such as laboratory, research, and industry‐based settings in SA. Using semi‐structured interviews, this research gathered data from qualified GCs employed in NDPC positions. Reflexive thematic analysis revealed three themes: No choice but to pivot , Quality of life , and Professional identity . These findings offer new insights into an unexplored topic and offer an in‐depth understanding of NDPC GCs based in SA, their motivations that drive this trend, and the evolving professional landscape of genetic counseling in SA. They address the scarcity of patient‐facing employment opportunities for qualified GCs, advocate for the inclusion of exposure to roles outside of clinical practice during training and highlight the potential to guide workforce policies to address the employment gap.